MILNE GEORGE M JR — SEC insider filings
SEC reporting owner CIK 1179552. 21 insider filings on record with FilingPulse; latest filed 2026-10-07.
Transaction summary — filings shown
Covers all 21 filings on record, filed 2021-03-02 to 2026-10-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 5 filings — 156,315 shares, $1,017,169 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 4 legs across 3 filings — 68,530 shares, $2,970,706 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 33,084 shares @ $31.86 ($1,053,901) in Amylyx Pharmaceuticals, Inc., filed 2023-03-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. (AMLX) | Director | 13 | 2 legs · 126,315 sh · $719,785 | 3 legs · 65,000 sh · $1,946,976 | 10 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Director | 2 | — | 1 leg · 3,530 sh · $1,023,730 | 5 |
| Aurinia Pharmaceuticals Inc. (AUPH) | Director | 6 | 3 legs · 30,000 sh · $297,384 | — | 5 |
Insider filings — MILNE GEORGE M JR
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-07 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale (S): 30,000 @ $27.70 | EDGAR |
| 2026-06-08 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/award (A): 24,372 (derivative) @ $0 | EDGAR |
| 2026-01-14 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Gift (G): 17,780 @ $0 | EDGAR |
| 2025-06-09 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-01-28 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Gift (G): 27,910 @ $0 | EDGAR |
| 2024-09-05 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Purchase (P): 100,000 @ $2.20 | EDGAR |
| 2024-06-07 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-01-29 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Gift (G): 9,100 @ $0 | EDGAR |
| 2024-01-18 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Gift (G): 94,350 @ $0 | EDGAR |
| 2023-06-12 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/award (A): 16,985 (derivative) @ $0 | EDGAR |
| 2023-05-23 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Option exercise (M): 8,733 · Option exercise (M): 8,733 (derivative) @ $0 | EDGAR |
| 2023-03-20 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale (S): 33,084 @ $31.86 · Sale (S): 1,916 @ $32.45 | EDGAR |
| 2023-03-06 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Purchase (P): 20,000 @ $8.91 | EDGAR |
| 2022-06-10 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2022-05-20 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/award (A): 8,733 (derivative) @ $0 · Grant/award (A): 14,612 (derivative) @ $0 | EDGAR |
| 2022-03-08 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Purchase (P): 5,000 @ $10.82 | EDGAR |
| 2022-01-10 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Purchase (P): 26,315 @ $19 · Grant/award (A): 8,400 (derivative) @ $0 | EDGAR |
| 2021-06-16 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/award (A): 31,347 (derivative) @ $0 | EDGAR |
| 2021-05-10 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Grant/award (A): 355 @ $0 · Grant/award (A): 307 @ $0 · Grant/award (A): 1,151 (derivative) @ $0 | EDGAR |
| 2021-03-09 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Purchase (P): 5,000 @ $13 | EDGAR |
| 2021-03-02 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Option exercise (M): 3,530 @ $52.29 · Sale (S): 3,530 @ $290.01 · Option exercise (M): 3,530 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-03-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1179552 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs